Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a Phase II, randomized study

PURPOSE: To evaluate the effect of immunotherapy on response, survival, and certain immune markers in patients with small cell lung cancer (SCLC) who are receiving chemotherapy. PATIENTS AND METHODS: Patients with SCLC (n = 164) were assigned to receive either chemotherapy alone (group A) or a combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Konstantinos, Ziogas, Eftimios, Boutsikou, Efimia, Zarogoulidis, Paul, Darwiche, Kaid, Kontakiotis, Theodoros, Tsakiridis, Kosmas, Porpodis, Konstantinos, Latsios, Dimitrios, Chatzizisi, Olga, Karapantzos, Ilias, Li, Qiang, Kyriazis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726438/
https://www.ncbi.nlm.nih.gov/pubmed/23901264
http://dx.doi.org/10.2147/DDDT.S43184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726438/
https://www.ncbi.nlm.nih.gov/pubmed/23901264
http://dx.doi.org/10.2147/DDDT.S43184

Ejemplares similares